Patent details

Herbas

VPB

Print

EN | LT

LT - PDL-1 ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF

EN - PDL-1 ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07K 16/28
		C12N 15/13
		C12N 5/20
		A61K 39/395
		A61P 35/00
		C07K 14/705
		A61P 35/02

European patent
(11)	Number of the document	3309177
(13)	Kind of document	T
(96)	European patent application number	17759275.5
	Date of filing the European patent application	2017-03-02
(97)	Date of publication of the European application	2018-04-18
(45)	Date of publication and mention of the grant of the patent	2020-05-13
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/CN2017/075484
	Date	2017-03-02

PCT application publication
(87)	Number	WO 2017/148424
	Date	2017-09-08

Priority applications
(30)	Number	Date	Country code
	201610122117	2016-03-04	CN

Inventors
(72)	LI, Baiyong, CN XUE, Tongtong, CN XIA, Yu, CN WANG, Zhongmin Maxwell, CN XIAO, Liang, CN WANG, Lichun, CN WANG, Jingyi, CN

Grantee
(73)	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., No.666, Xinhua Avenue (section 2) Hai Xia Industrial Park Wenjiang District, Chengdu, Sichuan 611138, CN

Title
(54)	PDL-1 ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF
	PDL-1 ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF